Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes

Fig. 1

Changes in plasma lipid profile (%) by treatment of DPP-4 inhibitor and SGLT2 inhibitor. TC Total cholesterol, TG Triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, Apo A apolipoprotein A, Apo B apolipoprotein B, Lp (a) lipoprotein (a). * p < 0.05 (comparison between DPP-4 inhibitor group and SGLT2 inhibitor group)

Back to article page